Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
View Top Employees from Omeros CorporationWebsite | http://www.omeros.com |
Ticker | OMER |
Revenue | $29 million |
Funding | $1 billion |
Employees | 252 (252 on RocketReach) |
Founded | 1994 |
Address | 201 Elliott Ave W, Seattle, Washington 98119, US |
Phone | (206) 676-5000 |
Fax | (206) 676-5005 |
Technologies |
JavaScript,
HTML,
PHP
+49 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Healthcare, Science and Engineering, Health Care, Pharmaceutical |
Web Rank | 2 Million |
Keywords | Small Molecule Drug Discovery, Orphan Drug Development, Rare Disease |
Competitors | Acceleron Pharma, Boston Life Sciences Inc, Dynavax Technologies, Vanda Pharmaceuticals, Xenon Pharmaceuticals Inc. |
SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Omeros Corporation employee's phone or email?
The Omeros Corporation annual revenue was $29 million in 2024.
252 people are employed at Omeros Corporation.
Omeros Corporation is based in Seattle, Washington.
The NAICS codes for Omeros Corporation are [3254, 32541, 325, 32].
The SIC codes for Omeros Corporation are [28, 2834, 283].